Carlyle: Travelers CEO steps off board to fight illness - 10/28/2015

In the Margins

Carlyle: Travelers CEO steps off board to fight illness

October 28, 2015

By Bloomberg

Carlyle Group LP said Travelers Cos. CEO Jay Fishman stepped down from its board while fighting amyotrophic lateral sclerosis, or ALS. Fishman, 62, said in August he would be replaced as Travelers CEO on Dec. 1 by Alan Schnitzer and stay on as executive chairman. Anthony Welters, executive chairman of investment company Black Ivy Group and a senior adviser to the office of the CEO at UnitedHealth Group Inc., has joined the Carlyle board as independent director. Read the original story from Bloomberg.

Share Feedback Post on LinkedIn Share Article

Most Read

A Seat at the Table
Dimensional, fund board ready early '26 ETF share class debut

Dimensional Fund Advisors is preparing to launch exchange-traded fund share classes of a selection of its open-end mutual funds in the early part of 2026, and ...

A Seat at the Table
We've had A Seat at the Table — for 10 years

The very first independent chair we profiled for FBV was Leigh Wilson at Victory Funds, for our A Seat at the Table section. Victory Capital Management had recently redefined itself ...

Top of the Agenda - Governance
SEC’s ETF share class move to spur board talks, planning

The Securities and Exchange Commission's move earlier this week to greenlight Dimensional Fund Advisors' plan to offer ETF share classes of its mutual funds is likely ...

Top of the Agenda - Governance
Fewer women, minorities among new fund directors

After years of making gains in filling fund board seats, women and individuals representing minority groups lost significant ground in the most recent two-year period measured ...